Score Overview
AC Immune Ltd fundamental performance
Between 2020 and 2025, revenue declined from CHF 15M to CHF 3M and net income went from -CHF 61M to -CHF 70M. Revenue increased in 4 of those 5 years; net income in 4.
Across AC Immune Ltd's full reported history, from 2016 to 2025, revenue declined from CHF 23M to CHF 3M and net income went from -CHF 7M to -CHF 70M. Revenue increased in 50% of the years measured; net income in 50%.
AC Immune Ltd currently holds a 5-year HDB Score of 6.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.62 | — |
1 Year2025-08-12 | $ 2.15 | 21.86% |
5 Years2021-08-12 | $ 6.82 | -61.58% |
All Time2016-09-23 | $ 15.66 | -83.27% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2016-09-23 |
|---|---|---|---|---|
| Price | $ 2.62 | $ 2.15 | $ 6.82 | $ 15.66 |
| Return | — | 21.86% | -61.58% | -83.27% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | CHF 17M | -CHF 43M | |
| 2025 | CHF 3M | -CHF 70M | CHF 91M |
| 2024 | CHF 27M | -CHF 50M | CHF 165M |
| 2023 | CHF 14M | -CHF 54M | CHF 103M |
| 2022 | CHF 3M | -CHF 70M | CHF 122M |
| 2021 | CHF 944K | -CHF 72M | CHF 198M |
| 2020 | CHF 15M | -CHF 61M | CHF 225M |
| 2019 | CHF 110M | CHF 45M | CHF 288M |
| 2018 | CHF 7M | -CHF 50M | CHF 186M |
| 2017 | CHF 20M | -CHF 26M | CHF 124M |
| IPO2016 | CHF 23M | -CHF 7M | CHF 152M |
Explore beyond ACIU
You're looking at AC Immune Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
